Personal information

Emails & domains

Verified email domains

Websites & social links

Mendeley profile

Other IDs

Scopus Author ID: 35515853400

Activities

Collapse all

Employment (9)

University of Washington: Seattle, WA, US

2020-08-17 to present | Professor (Department of Laboratory Medicine & Pathology)
Employment
Source: Self-asserted source
Kikkeri N Naresh

Fred Hutchinson Cancer Research Center: Seattle, WA, US

2020-08-17 to present | Section Head of Pathology & Professor (Pathology)
Employment
Source: Self-asserted source
Kikkeri N Naresh

Imperial College London: London, London, GB

2004-01-01 to present | Visiting Professor; Professor of Practice (Pathology) (Centres for Pathology & Haematology)
Employment
Source: Self-asserted source
Kikkeri N Naresh

Imperial College Healthcare NHS Trust: London, London, GB

2004-01-01 to 2020-08-13 | Consultant Haematopathologist, Professor; also served in the roles of Chief of Service / Clinical Director of Pathology & Divisional Director of Investigative Sciences (Pathology)
Employment
Source: Self-asserted source
Kikkeri N Naresh

Imperial College Health Partners: London, London, GB

2016-08-01 to 2020-03-31 | Clinical Director (West London Genomic Medicine Centre)
Employment
Source: Self-asserted source
Kikkeri N Naresh

Tata Memorial Hospital: Mumbai, Maharashtra, IN

1992-04-01 to 2003-12-31 | Associate Professor of Pathology followed by Professor of Pathology (Addl.) (Pathology)
Employment
Source: Self-asserted source
Kikkeri N Naresh

Kidwai Memorial Institute of Oncology: Bangalore, Karnataka, IN

1989-08-01 to 1992-04-01 | Lecturer (Pathology)
Employment
Source: Self-asserted source
Kikkeri N Naresh

St. Martha's Hospital, Bangalore, India: Bangalore, IN

1989-04-01 to 1989-08-01 | Pathologist (Pathology)
Employment
Source: Self-asserted source
Kikkeri N Naresh

Dr. B.R. Ambedkar Medical College, Bangalore, India: Bangalore, IN

1988-12-01 to 1989-03-31 | Lecturer (Pathology)
Employment
Source: Self-asserted source
Kikkeri N Naresh

Education and qualifications (5)

Royal College of Pathologists: London, London, GB

2007-01-01 to 2007-11-01 | FRCPath
Education
Source: Self-asserted source
Kikkeri N Naresh

Royal College of Pathologists: London, London, GB

2001-01-01 to 2001-11-01 | MRCPath
Education
Source: Self-asserted source
Kikkeri N Naresh

Jawaharlal Institute of Post Graduate Medical Education: Pondicherry, Puducherry, IN

1986-07-01 to 1988-07-01 | MD - Pathology (Pathology)
Education
Source: Self-asserted source
Kikkeri N Naresh

Mysore Medical College: Mysore, Karnataka, IN

1983-07-01 to 1985-07-01 | Diploma in Clinical Pathology (Pathology)
Education
Source: Self-asserted source
Kikkeri N Naresh

Mysore Medical College: Mysore, Karnataka, IN

1975-07-01 to 1981-07-01 | MBBS
Education
Source: Self-asserted source
Kikkeri N Naresh

Works (50 of 431)

Items per page:
Page 1 of 9

A Systematic Approach to Prioritise Diagnostically Useful Findings for Inclusion in Electronic Health Records as Discrete Data to Improve Clinical Artificial Intelligence Tools and Genomic Research.

Clinical oncology (Royal College of Radiologists (Great Britain))
2024-12 | Journal article
DOI: 10.1016/j.clon.2024.103737
PMID: 39837110
Contributors: Guillod P; Savvas A; Robinson PN; Nai D; Naresh KN; Ott G; Schuh A; Sewell WA; Anderson M; Matentzoglu N et al.
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series.

Blood advances
2024-10 | Journal article
DOI: 10.1182/bloodadvances.2024013791
PMID: 39189932
Contributors: Epperla N; Zayac AS; Landsburg DJ; Bock AM; Nowakowski GS; Ayers EC; Girton M; Hu M; Beckman A; Li S et al.
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma.

Blood cancer journal
2024-10 | Journal article
DOI: 10.1038/s41408-024-01167-8
PMID: 39414769
PMC: PMC11484697
Contributors: Fortuna GG; Banerjee R; Savid-Frontera C; Song J; Morán-Segura CM; Nguyen JV; Lekakis L; Fernandez-Pol S; Samraj AN; Naresh KN et al.
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Understanding splenic B-cell lymphoma/leukaemia with prominent nucleoli: Diagnosis, underpinnings for disease classification and future directions.

British journal of haematology
2024-09 | Journal article
DOI: 10.1111/bjh.19754
PMID: 39253895
Contributors: Naresh KN
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Utility of CCR7 to differentiate classic Hodgkin lymphoma and other B-cell lymphomas by flow cytometry and immunohistochemistry.

American journal of clinical pathology
2024-09 | Journal article
DOI: 10.1093/ajcp/aqae119
PMID: 39288406
Contributors: Chen X; Soma L; Murphy C; Tretiakova M; Naresh KN; Fromm JR
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Complete loss of lineage defining antigens in two cases of B-cell malignancies following CAR-T therapy.

Journal of hematopathology
2024-08 | Journal article
DOI: 10.1007/s12308-024-00602-w
PMID: 39186243
Contributors: Torabi A; Love J; Hyun T; Pham A; Gauthier J; Hirayama A; Wu D; Naresh K
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Immune Effector Cell-Associated Enterocolitis following Chimeric Antigen Receptor T-cell Therapy in Multiple Myeloma

2024-08 | Preprint
DOI: 10.21203/rs.3.rs-4727434/v1
PPR: PPR893635
Contributors: Fortuna GMG; Banerjee R; Song J; Lekakis L; Fernandez-Pol S; Samraj AN; Naresh KN; Vazquez-Martinez M; Baz RC; Spiegel JY et al.
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

PD-L1<sup>+</sup> macrophage and tumor cell abundance and proximity to T cells in the pretreatment large B-cell lymphoma microenvironment impact CD19 CAR-T cell immunotherapy efficacy.

HemaSphere
2024-08 | Journal article
DOI: 10.1002/hem3.142
PMID: 39113729
PMC: PMC11303978
Contributors: Hirayama AV; Wright JH; Smythe KS; Fiorenza S; Shaw AN; Gauthier J; Maloney DG; Naresh KN; Yeung CCS; Turtle CJ
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Does a subset of mature T‐cell leukemias with features akin to T‐cell prolymphocytic leukemia but lacking rearrangement of the TCL1 represent peripheral T‐cell lymphoma, NOS in a leukemic phase?

EJHaem
2024-06 | Journal article
PMC: PMC11327743
Contributors: Gajzer D; Chen X; Sabath D; Poh C; Naresh K
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Mature T-cell, NK-cell and Stroma-Derived Neoplasms of Lymphoid Tissues.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2024-05 | Journal article
DOI: 10.1016/j.modpat.2024.100512
PMID: 38734236
Contributors: Miranda RN; Amador C; Chan JKC; Guitart J; Rech KL; Medeiros LJ; Naresh KN; WHO 5(th) edition classification project
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Assessment for 11q and other chromosomal aberrations in large B-cell/high-grade B cell lymphomas of germinal center phenotype lacking BCL2 expression.

Cancer genetics
2024-03 | Journal article
DOI: 10.1016/j.cancergen.2024.03.001
PMID: 38520765
Contributors: Ho CC; Naresh K; Liu Y; Wu Y; Gopal AK; Eckel AM
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Classification of Haematolymphoid Neoplasms: A work in progress towards more precise disease definitions in the era of precision oncology.

The National medical journal of India
2024-03 | Journal article
DOI: 10.25259/nmji_918_2024
PMID: 39222529
Contributors: Naresh KN
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Fifth Edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Acute Lymphoblastic Leukemias, Mixed-Phenotype Acute Leukemias, Myeloid/Lymphoid Neoplasms With Eosinophilia, Dendritic/Histiocytic Neoplasms, and Genetic Tumor Syndromes.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2024-03 | Journal article
DOI: 10.1016/j.modpat.2024.100466
PMID: 38460674
Contributors: Choi JK; Xiao W; Chen X; Loghavi S; Elenitoba-Johnson KS; Naresh KN; Medeiros LJ; Czader M; WHO 5th Edition Classification Project
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

5th Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: B-cell Neoplasms.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2024-02 | Journal article
DOI: 10.1016/j.modpat.2024.100441
PMID: 38309432
Contributors: Medeiros LJ; Chadburn A; Natkunam Y; Naresh KN; WHO 5th Edition Classification Project
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Mature plasmacytoid dendritic cell proliferation in association with mixed-phenotype acute leukemia, T/myeloid.

Blood
2024-02 | Journal article
DOI: 10.1182/blood.2023022748
PMID: 38329773
Contributors: Qiu L; Naresh KN
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Use of CD32, CD44 and CD71 to differentiate follicular lymphoma and diffuse large B-cell lymphoma subtypes by flow cytometry.

Journal of clinical pathology
2024-02 | Journal article
DOI: 10.1136/jcp-2023-209366
PMID: 38336474
Contributors: Schwarz LW; Love JE; Naresh KN; Shameli A; Fromm JR
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

The 5th edition of the World Health Organization Classification of mature lymphoid and stromal tumors - an overview and update.

Leukemia & lymphoma
2024-01 | Journal article
DOI: 10.1080/10428194.2023.2297939
PMID: 38189838
Contributors: Attygalle AD; Chan JKC; Coupland SE; Du MQ; Ferry JA; Jong D; Gratzinger D; Lim MS; Naresh KN; Nicolae A et al.
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

The fifth edition of the WHO classification of mature B-cell neoplasms: open questions for research.

The Journal of pathology
2024-01 | Journal article
DOI: 10.1002/path.6246
PMID: 38180354
Contributors: Coupland SE; Du MQ; Ferry JA; de Jong D; Khoury JD; Leoncini L; Naresh KN; Ott G; Siebert R; Xerri L et al.
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

5<sup>TH</sup> EDITION OF THE WORLD HEALTH CLASSIFICATION OF TUMORS OF THE HEMATOPOIETIC AND LYMPHOID TISSUES.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2023-12 | Journal article
DOI: 10.1016/j.modpat.2023.100397
PMID: 38043791
Contributors: Loghavi S; Kanagal-Shamanna R; Khoury JD; Medeiros LJ; Naresh KN; Nejati R; Patnaik MM; WHO 5th Edition Classification Project
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Clinical Validation of FusionPlex RNA Sequencing and Its Utility in the Diagnosis and Classification of Hematologic Neoplasms.

The Journal of molecular diagnostics : JMD
2023-10 | Journal article
DOI: 10.1016/j.jmoldx.2023.09.007
PMID: 37813298
Contributors: Chen X; Wang W; Yeh J; Wu Y; Oehler VG; Naresh KN; Liu YJ
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Leukemic non-nodal cyclin D1- and SOX11-negative mantle cell lymphoma with CCND3::IGH rearrangement.

Annals of hematology
2023-10 | Journal article
DOI: 10.1007/s00277-023-05514-w
PMID: 37882866
Contributors: Tan L; Bansal G; Yeung CC; Yin J; Dave BJ; Konnick E; Wu D; Naresh KN
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Introduction to the Fifth Edition of the World Health Organization Classification of Tumors of Hematopoietic and Lymphoid Tissues.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
2023-09 | Journal article
DOI: 10.1016/j.modpat.2023.100330
PMID: 37716508
Contributors: Naresh KN; Medeiros LJ; WHO Fifth Edition Classification Project
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Abnormal bone marrow findings in patients following treatment with chimeric antigen receptor-T cell therapy.

European journal of haematology
2023-08 | Journal article
DOI: 10.1111/ejh.14068
PMID: 37526606
Contributors: Yeung CCS; Woolston DW; Wu V; Voutsinas JM; Basom R; Davis C; Hirayama AV; Naresh KN
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748.

Leukemia
2023-07 | Journal article
DOI: 10.1038/s41375-023-01962-5
PMID: 37468552
Contributors: Alaggio R; Amador C; Anagnostopoulos I; Attygalle AD; de Oliveira Araujo IB; Berti E; Bhagat G; Borges AM; Boyer D; Calaminici M et al.
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

T-cell prolymphocytic leukemia/lymphoma with TCRB::TCL1 translocation.

Blood
2023-07 | Journal article
DOI: 10.1182/blood.2023020401
PMID: 37410504
Contributors: Torabi A; Naresh KN
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study.

Blood advances
2023-05 | Journal article
DOI: 10.1182/bloodadvances.2023009731
PMID: 37171397
Contributors: Zayac AS; Landsburg DJ; Hughes ME; Bock AM; Nowakowski GS; Ayers EC; Girton MR; Hu M; Beckman AK; Li S et al.
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications.

Blood cancer journal
2023-04 | Journal article
DOI: 10.1038/s41408-023-00827-5
PMID: 37072385
PMC: PMC10113386
Contributors: El-Sharkawi D; Sud A; Prodger C; Khwaja J; Shotton R; Hanley B; Peacock V; Peng YY; Arasaretnam A; Sharma S et al.
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Aleukemic mast cell leukemia, well-differentiated and chronic type.

Annals of hematology
2023-04 | Journal article
DOI: 10.1007/s00277-023-05195-5
PMID: 37016166
Contributors: Chen K; Hendrie PC; Naresh KN
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

MEF2B is the ideal immunohistochemical marker to highlight neoplastic LP cells in nodular lymphocyte-predominant Hodgkin lymphoma.

EJHaem
2023-04 | Journal article
DOI: 10.1002/jha2.690
PMID: 37206275
PMC: PMC10188466
Contributors: Torabi A; Fromm JR; Naresh KN
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Response to the Comments from the Groupe Francophone de Cytogénétique Hématologique (GFCH) on the 5th edition of the World Health Organization classification of haematolymphoid tumors.

Leukemia
2023-03 | Journal article
DOI: 10.1038/s41375-023-01872-6
PMID: 36973349
Contributors: Siebert R; Schuh A; Ott G; Cree IA; Du MQ; Ferry J; Hochhaus A; Naresh KN; Solary E; Khoury JD
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

P048: Predictors of risk of relapse in classic Hodgkin lymphoma by flow cytometry

HemaSphere
2022-10 | Journal article
PMC: PMC9621501
Contributors: Fromm J; Tang C; Naresh K
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Predictors of risk of relapse in classic Hodgkin lymphoma.

Journal of clinical pathology
2022-10 | Journal article
DOI: 10.1136/jcp-2022-208552
PMID: 36241372
Contributors: Fromm JR; Tang C; Naresh KN
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type Diffuse Large B Cell Lymphoma.

Blood advances
2022-08 | Journal article
DOI: 10.1182/bloodadvances.2022007536
PMID: 35947123
Contributors: Bewicke-Copley F; Korfi K; Araf S; Hodkinson B; Kumar E; Cummin T; Ashton-Key M; Barrans SL; van Hoppe SJ; Burton C et al.
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Proposal of 'reactive-lymphocyte/histiocyte rich large B-cell lymphoma' as an alternate term for 'nodular lymphocyte predominant Hodgkin lymphoma' that would also address its overlap with T-cell/histiocyte rich large B-cell lymphoma.

EJHaem
2022-08 | Journal article
DOI: 10.1002/jha2.560
PMID: 36467810
Contributors: Naresh KN
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

The impact of histological grade on outcomes in follicular lymphoma: An analysis of patients in the SEER database in the context of evolving disease classification and treatment.

British journal of haematology
2022-08 | Journal article
DOI: 10.1111/bjh.18404
PMID: 35973829
Contributors: Naik A; Gooley T; Loeb K; Soma L; Smith SD; Gopal A; Naresh KN
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

Leukemia
2022-06 | Journal article
PMC: PMC9214472
Contributors: Alaggio R; Amador C; Anagnostopoulos I; Attygalle A; Araujo I; Berti E; Bhagat G; Borges A; Boyer D; Calaminici M et al.
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

Leukemia
2022-06 | Journal article
DOI: 10.1038/s41375-022-01620-2
PMID: 35732829
Contributors: Alaggio R; Amador C; Anagnostopoulos I; Attygalle AD; Araujo IBO; Berti E; Bhagat G; Borges AM; Boyer D; Calaminici M et al.
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.

Leukemia
2022-06 | Journal article
DOI: 10.1038/s41375-022-01613-1
PMID: 35732831
Contributors: Khoury JD; Solary E; Abla O; Akkari Y; Alaggio R; Apperley JF; Bejar R; Berti E; Busque L; Chan JKC et al.
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Variant histology in nodular lymphocyte predominant Hodgkin lymphoma in an adult population: disease investigations and characteristics from a retrospective cohort.

Journal of clinical pathology
2022-04 | Journal article
DOI: 10.1136/jclinpath-2022-208190
PMID: 35483890
Contributors: Stacey A; Marks AJ; Naresh KN
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

CD5+ Gamma Delta T-Cell Lymphoproliferative Disorder/Lymphoma Without Cytotoxic Granules in the Skin.

The American Journal of dermatopathology
2022-03 | Journal article
DOI: 10.1097/dad.0000000000002171
PMID: 35234187
Contributors: Ju JY; Sorensen EP; Walsh JS; Shinohara MM; Naresh KN
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis.

Histopathology
2022-03 | Journal article
DOI: 10.1111/his.14619
PMID: 35064935
Contributors: Attygalle AD; Dobson R; Chak PK; Vroobel KM; Wren D; Mugalaasi H; Morgan Y; Kaur M; Ahmad R; Chen Z et al.
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Report of a Case With Clinical and Pathologic Features of Castleman Disease That Predates Castleman's Report by More Than 50 Years.

Archives of pathology & laboratory medicine
2022-03 | Journal article
DOI: 10.5858/arpa.2021-0205-hp
PMID: 35286379
Contributors: Pai SA; Naresh KN; Borges AM
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Systems medicine dissection of chr1q-amp reveals a novel PBX1-FOXM1 axis for targeted therapy in multiple myeloma.

Blood
2022-03 | Journal article
DOI: 10.1182/blood.2021014391
PMID: 35015835
Contributors: Trasanidis N; Katsarou A; Ponnusamy K; Shen YA; Kostopoulos IV; Bergonia B; Keren K; Reema P; Xiao X; Szydlo RM et al.
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study.

The Lancet. Neurology
2022-03 | Journal article
DOI: 10.1016/s1474-4422(21)00462-2
PMID: 35182509
PMC: PMC8850201
Contributors: Ibañez K; Polke J; Hagelstrom RT; Dolzhenko E; Pasko D; Thomas ERA; Daugherty LC; Kasperaviciute D; Smith KR; WGS for Neurological Diseases Group et al.
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

"Blasts" in myeloid neoplasms - how do we define blasts and how do we incorporate them into diagnostic schema moving forward?

Leukemia
2022-01 | Journal article
DOI: 10.1038/s41375-021-01498-6
PMID: 35042955
Contributors: Chen X; Fromm JR; Naresh KN
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis.

Wiley
2022-01-19 | Journal article
DOI: 10.17863/cam.80182
Contributors: AYOMA D ATTYGALLE; Rachel Dobson; Pui Kwan Chak; Katherine M Vroobel; Dorte Wren; Hood Mugalaasi; Yvonne Morgan; Manmit Kaur; Raida Ahmad; Zi Chen et al.
Source: check_circle
DataCite

100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report.

The New England journal of medicine
2021-11 | Journal article
DOI: 10.1056/nejmoa2035790
PMID: 34758253
Contributors: 100; 000 Genomes Project Pilot Investigators; Smedley D; Smith KR; Martin A; Thomas EA; McDonagh EM; Cipriani V; Ellingford JM; Arno G et al.
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

A refined approach to the diagnosis of Burkitt lymphoma in a resource-poor setting.

Histopathology
2021-11 | Journal article
DOI: 10.1111/his.14594
PMID: 34725849
Contributors: Naresh KN; Lazzi S; Santi R; Granai M; Onyango N; Leoncini L
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Systems medicine dissection of chromosome 1q amplification reveals oncogenic regulatory circuits and informs targeted therapy in cancer

2021-11 | Preprint
DOI: 10.1101/2021.11.17.469031
PPR: PPR422702
Contributors: Trasanidis N; Katsarou A; Ponnusamy K; Shen Y; Kostopoulos IV; Bergonia B; Keren K; Reema P; Xiao X; Szydlo RM et al.
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central

Carfilzomib Enhances the Suppressive Effect of Ruxolitinib in Myelofibrosis.

Cancers
2021-09 | Journal article
DOI: 10.3390/cancers13194863
PMID: 34638347
PMC: PMC8507927
Contributors: Claudiani S; Mason CC; Milojkovic D; Bianchi A; Pellegrini C; Di Marco A; Fiol CR; Robinson M; Ponnusamy K; Mokretar K et al.
Source: Self-asserted source
Kikkeri N Naresh via Europe PubMed Central
Items per page:
Page 1 of 9

Peer review (10 reviews for 3 publications/grants)

Review activity for Journal of hematopathology. (2)
Review activity for Leukemia (7)
Review activity for Modern pathology. (1)
How many people are using ORCID?